Raphael Wishiewski is listed as a director on 5 SEC Form D filings by 1 issuer between Jun 2011 and Jan 2013: Regado Biosciences Inc (Basking Ridge, NJ — biotechnology — 2011–2013; $40M reported sold to 15 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David J. Mazzo (5 shared filings), Dennis Podlesak (5 shared filings), Jesse Treu (5 shared filings), P. Sherrill Neff (5 shared filings), Jeff Clark (4 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Raphael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Raphael Wishiewski and found 7 differences: Form D filed 30 days after the first sale; Form D filed 18 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.